Close Menu

NEW YORK (GenomeWeb) – Oxford BioDynamics announced today that it has signed a collaboration agreement with Holos Life Sciences to develop non-invasive epigenetic biomarkers linked to sports-related concussions.

Under the terms of the agreement, Holos will supply the participants' blood samples, while Oxford will provide its EpiSwitch platform and methodology for the development, evaluation, and validation of epigenetic biomarkers. The test's biomarker readouts will be based on minimally invasive blood testing.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Wired reports on how genetic genealogy's use in forensics has exploded in the year since an arrest in the Golden State Killer case was made.

Retraction Watch reports that the increase in retracted papers at a journal is due to more resources there to tackle publication ethics.

New York City has settled with a forensic scientist who was fired after questioning a DNA testing approach used by the medical examiner's office, the New York Times reports.

In Nature this week: technique for measuring replication fork movement, WINTHER trial results, and more.